Composition
- Active ingredients
- LANSOPRAZOLE 30MG/PACKET
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- LANSOPRAZOLE 15MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Capsule, delayed rel pelletsNDA020406-001 · Discontinued
- LANSOPRAZOLE 30MG · Capsule, delayed rel pelletsNDA020406-002 · Prescription
- LANSOPRAZOLE 30MG/PACKET · For suspension, delayed releaseThis page
- LANSOPRAZOLE 15MG/PACKET · For suspension, delayed releaseNDA021281-001 · Discontinued
- LANSOPRAZOLE 30MG · Tablet, orally disintegrating, delayed releaseNDA021428-002 · Prescription
- LANSOPRAZOLE 15MG · Tablet, orally disintegrating, delayed releaseNDA021428-001 · Prescription
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA021281.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Prevacid
- Active substance
- lansoprazole
- Route
- Oral
- Dosage form
- For suspension, delayed release
- Applicant
- Takeda Pharms Na
- Status
- Discontinued
- FDA approval
- 3 May 2001
- Application
- NDA021281-002



